Case Study

Taking the Strain: Scalable Vaccine Production

Format: PDF file | Document type: Case Study | Promoted Content

This content is provided by Eppendorf Bioprocess Solutions, and any views and opinions expressed do not necessarily reflect those of


Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line – used worldwide and approved by the US Food and Drug Administration – as well as media technology and the bioreactor options available.

Related resources from Eppendorf Bioprocess Solutions

Show more

Supplier info centre